Venquis Therapeutics, Inc. — Form D
Venquis Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-05. The offering totals $5.0M, of which $100K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-10-05
- Form: D
- Accession: 0001886124-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $100K
- Remaining: $4.9M
- Investors: 1
- Date of first sale: 2021-09-24
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-415633
Issuer
- Name: Venquis Therapeutics, Inc.
- CIK: 0001886124
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 10179 HUENNEKENS ST., STE 208, SAN DIEGO, CA, 92121
- Phone: 858-353-2090
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Robin M Jackman | Director | San Diego, CA |
| Raj K Raheja | Director | San Diego, CA |
| Zhiyong K Wang | Director | San Diego, CA |
| Robin M Jackman | Executive Officer | San Diego, CA |
| Raj K Raheja | Executive Officer | San Diego, CA |
| Zhiyong K Wang | Executive Officer | San Diego, CA |
More